A Study of People With Type 2 Diabetes Who Have Diseases That Affect the Heart and Blood Vessels. The Study Will Also Look at the Treatment of a Group of These People in Hospitals in Portugal

Hypoglycaemic episodes

Number of episodes

Time frame: During 3 years before baseline (0 to -36 months)

Hyperglycaemic episodes

Number of episodes

Time frame: During 3 years before baseline (0 to -36 months)

Presence of T2DM complications (yes/no)

Number of patients for whom 'presence of T2DM complications' has been answered yes/no respectively

Time frame: During 3 years before baseline (0 to -36 months)

Types of T2DM complications

Types of T2DM complications: Retinopathy, Diabetic neuropathy (peripheral, autonomic), Diabetic nephropathy, Amputation.

Time frame: During 3 years before baseline (0 to -36 months)

Hospital appointments

Number of cardiology, ophthalmology, nephrology, and vascular surgery appointments

Time frame: During 3 years before baseline (0 to -36 months)

Hospitalisation episodes

Number of episodes

Time frame: During 3 years before baseline (0 to -36 months)

Emergency visits

Number of visits

Time frame: During 3 years before baseline (0 to -36 months)

Change in waist circumference

Measured in cm

Time frame: During 3 years before baseline (0 to -36 months)

Change in body mass index

Measured in kg/m\^2

Time frame: During 3 years before baseline (0 to -36 months)

Change in blood pressure

Measured in mmHg

Time frame: During 3 years before baseline (0 to -36 months)

Change in urine albumin

Measured in mg/24 hours

Time frame: During 3 years before baseline (0 to -36 months)

Change in urine albumin

Measured in microgram/minute

Time frame: During 3 years before baseline (0 to -36 months)

Change in glycosylated hemoglobin (HbA1c)

Measured in mmol/mol

Time frame: During 3 years before baseline (0 to -36 months)

Change in HbA1c

Measured in %

Time frame: During 3 years before baseline (0 to -36 months)

Change in Estimated Glomerular Filtration Rate (eGFR)

Measured in mL/min/1.73 m\^2

Time frame: During 3 years before baseline (0 to -36 months)

Change in total cholesterol

measured in mg/dl

Time frame: During 3 years before baseline (0 to -36 months)

Change in low-density lipoprotein cholesterol

measured in mg/dl

Time frame: During 3 years before baseline (0 to -36 months)

Change in high-density lipoprotein cholesterol

measured in mg/dl

Time frame: During 3 years before baseline (0 to -36 months)

Change in triglyceride

measured in mg/dl

Time frame: During 3 years before baseline (0 to -36 months)

Type of pharmacological treatment

Types of pharmacological treatment: Antidiabetics Antihypertensive Lipid lowering therapy Antiplatelet/anticoagulant therapy

Time frame: During 3 years before baseline (0 to -36 months)